Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 1.140
+0.010 (0.88%)
Jul 14, 2026, 1:28 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €179.74 thousand as of July 14, 2026. Its market cap has decreased by -59.15% in one year.
Market Cap
179.74K
Enterprise Value
311.89K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.14
Market Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 179.74K, a decrease of -70.04%. That is a compound annual growth rate of -66.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 179.74K | 4,296.82% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.27M |
| Aelis Farma | 14.28M |
| NFL Biosciences | 10.77M |
| Poxel | 10.64M |
| Aton | 8.78M |
| Plant Advanced Technologies | 7.59M |
| Oncodesign Precision Medicine Société anonyme | 6.53M |
| TME Pharma | 6.32M |